The menstrual cycle is a health signal
ACOG recommends treating the menstrual cycle as a vital sign in adolescent care. In well-nourished populations, median menarche is generally between 12 and 13 years, although timing varies with genetics, health, nutrition and context [1]. Early cycles can be irregular, but education should explain what is expected and which patterns need review.
Most adolescent cycles occur every 21 to 45 days and bleeding usually lasts no more than seven days [2]. A cycle outside these ranges is not automatically a disease, but it deserves assessment when persistent or accompanied by heavy bleeding, anaemia symptoms, severe pain, pregnancy possibility, endocrine symptoms, rapid weight change or major exercise load. Tracking dates, flow, pain, missed activities and treatments tried can make the clinical history more precise.
- Ask about the first day of the last period and the usual pattern at preventive visits.
- Measure impact on school, sleep, sport and ordinary activity.
- Protect adolescent confidentiality while explaining its legal and safety limits.
Heavy bleeding can be the first clue to a bleeding disorder
Heavy menstrual bleeding is defined by interference with physical, social, emotional or material quality of life, not only a measured volume. Soaking products very rapidly, bleeding through clothes or bedding, large clots, prolonged bleeding, dizziness, breathlessness or fatigue warrant evaluation. ACOG reports that bleeding disorders are found in about 20% of adolescents evaluated for heavy menstrual bleeding and about 33% of those hospitalised [2].
Assessment can include anaemia and iron deficiency, pregnancy where relevant, endocrine causes and bleeding-disorder history. Questions about easy bruising, nosebleeds, prolonged bleeding after dental work and family history matter. Acute heavy bleeding with fainting, chest symptoms, severe weakness or haemodynamic concern requires urgent care. Digital cycle logs help recall, but an algorithm should not reassure away red flags.
- Ask how often products are changed and whether bleeding reaches clothes or bedding.
- Check for anaemia and a personal or family bleeding history when indicated.
- Escalate acute instability rather than waiting for routine follow-up.
Disabling pain is not a rite of passage
Primary dysmenorrhoea is common and usually responds to appropriate first-line treatment. When pain remains clinically significant after three to six months of treatment, or symptoms suggest a secondary cause, further evaluation is needed [3]. Endometriosis is a leading cause of secondary dysmenorrhoea in adolescents. Symptoms can include progressive period pain, chronic pelvic pain, bowel or urinary symptoms linked to the cycle, pain with sexual activity and a family history.
ACOG's earlier adolescent guidance reported that at least two thirds of adolescents undergoing laparoscopy for chronic pelvic pain or dysmenorrhoea unresponsive to hormonal therapy and NSAIDs were diagnosed with endometriosis [3]. This figure applies to a highly selected surgical population, not all adolescents with cramps. It shows why persistent treatment-resistant pain should not be dismissed.
- Record which medicines were used, dose timing, adherence and response.
- Ask about bowel, bladder and non-menstrual pain.
- Refer persistent or complex symptoms to adolescent gynaecology or an endometriosis service.
Diagnosis can proceed without waiting for surgery
Updated NICE guidance recommends carrying out investigation and initial treatment in parallel. Ultrasound can identify endometriomas, deep endometriosis or other pathology, but normal imaging does not exclude endometriosis, particularly superficial disease [4]. Young people aged 17 and under with suspected or confirmed disease should be referred to a paediatric and adolescent gynaecology or specialist endometriosis service [4].
Evaluation should be age-appropriate and trauma-informed. A pelvic examination is not automatically required for every adolescent, and imaging route should reflect clinical need, acceptability and consent. Treatment is individualised around pain, menstrual suppression preferences, contraception needs, adverse effects and future fertility. Long-term opioids are not a routine solution for adolescent endometriosis.
- Explain what each examination or scan can and cannot show.
- Do not use serum CA-125 to diagnose endometriosis [4].
- Treat symptoms and continue evaluation when clinical concern persists.
A better pathway connects health, education and dignity
WHO frames menstrual health as a physical, psychological and social health and human-rights issue, not merely hygiene [5]. Adolescents need accurate information, products, water and sanitation, permission to participate fully in school and sport, and access to competent care. A clinical pathway that prescribes medication but ignores period poverty, school toilet access or stigma is incomplete.
Technology can support private symptom tracking, reminders and referral, but adolescent privacy needs deliberate design. Shared family accounts, lock-screen notifications and insurance communications can expose sensitive information. Platforms should minimise data, allow discreet contact preferences and explain who can see entries. The most useful metric is not app engagement. It is earlier recognition, fewer missed days, corrected anaemia and pain that no longer controls a young person's life.
- Provide school-facing care plans when the adolescent wants them.
- Ask whether products, toilets, cost or stigma limit participation.
- Build confidential digital communication appropriate to local law.
What the evidence cannot yet answer
- The true population prevalence of adolescent endometriosis remains uncertain because definitive diagnosis and study sampling differ.
- The two-thirds figure comes from adolescents selected for laparoscopy after persistent symptoms and must not be generalised to all period pain.
- Normal ultrasound cannot exclude all endometriosis, and no single biomarker currently provides a definitive non-invasive diagnosis.
Questions worth taking into care
- How often do periods occur, how long do they last and what activities are missed?
- Are there signs of anaemia or a personal or family bleeding tendency?
- Has pain persisted despite correctly used first-line treatment for three to six months?
- What bowel, bladder or non-menstrual symptoms occur?
- Are cost, product access, toilets, privacy or stigma creating additional harm?
Source record
Evidence used in this review
Sources were selected for clinical authority, methodological relevance and traceability. Links open the original guidance, public-health record or research publication.
- [1]Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign
American College of Obstetricians and Gynecologists · 2015
- [2]Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding
American College of Obstetricians and Gynecologists · 2019
- [3]Dysmenorrhea and Endometriosis in the Adolescent
American College of Obstetricians and Gynecologists · 2018
- [4]Endometriosis: Diagnosis and Management
National Institute for Health and Care Excellence · 2024
- [5]WHO Statement on Menstrual Health and Rights
World Health Organization · 2022
- [6]Time to Diagnose Endometriosis: Current Status, Challenges and Regional Characteristics
Journal of Clinical Medicine · 2024
This evidence synthesis is for general information. It does not diagnose a condition or replace care from a qualified health professional. Treatment choices depend on individual history, examination, local guidance and informed preference. Emergency or rapidly worsening symptoms need urgent local medical assessment.



